Table 1.
Associations between clinicopathological factors and MGP expression in 71 GC patients.
| Variables | MGP | χ2 | P‐value | |
|---|---|---|---|---|
| Positive (n = 52) | Negative (n = 19) | |||
| Gender | ||||
| Male | 37 | 16 | 2.0384 | 0.1534 |
| Female | 15 | 3 | ||
| Age (years) | ||||
| ≥ 65 | 24 | 6 | 1.2115 | 0.2710 |
| < 65 | 28 | 13 | ||
| Tumor size(cm) | ||||
| ≥ 5 | 32 | 9 | 1.1451 | 0.2846 |
| < 5 | 20 | 10 | ||
| T stage | ||||
| T1, T2 | 7 | 5 | 2.6802 | 0.1016 |
| T3, T4 | 45 | 14 | ||
| Lymph node metastasis | ||||
| Negative | 13 | 10 | 4.8513 | 0.0276 |
| Positive | 39 | 9 | ||
| Distant metastasis | ||||
| Negative | 47 | 16 | 0.0927 | 0.7608 |
| Positive | 5 | 3 | ||
| Pathological stage | ||||
| I–II, II | 16 | 4 | 0.6493 | 0.4204 |
| II–III, III | 36 | 15 | ||
| Clinical stage | ||||
| I, II | 27 | 9 | 0.1155 | 0.7340 |
| III, IV | 25 | 10 | ||